Human Bcl9-2 Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | AF4967SP-Each-of-1 | In Stock | ₹ 17,844.50 |
AF4967SP - Each of 1
In Stock
Quantity
1
Base Price: ₹ 17,844.50
GST (18%): ₹ 3,212.01
Total Price: ₹ 21,056.51
Antigen
BCL9-2
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
B-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, Bcl92, BCL9-like protein, DLNB11, DLNB11BCL9-2, nuclear co-factor of beta-catenin signalling, Protein BCL9-2
Host Species
Sheep
Purification Method
Affinity Purified
Regulatory Status
RUO
Gene ID (Entrez)
283149
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Applications
Western Blot
Concentration
LYOPH
Dilution
Western Blot 1 ug/mL
Gene Accession No.
Q86UU0
Gene Symbols
BCL9L
Immunogen
E. coli-derived recombinant human Bcl9-2 Met38-Val206 Accession # Q86UU0
Quantity
25 μg
Primary or Secondary
Primary
Test Specificity
Detects endogenous human Bcl9-2 in Western blots.
Target Species
Human
Isotype
IgG
Related Products
Description
- BCL9-2 Polyclonal specifically detects BCL9-2 in Human samples
- It is validated for Western Blot.